Stay updated on Johnson & Johnson Press Releases
Sign up to get notified when there's something new on the Johnson & Johnson Press Releases page.

Latest updates to the Johnson & Johnson Press Releases page
- Check5 days agoChange DetectedThe webpage has added significant updates regarding new product launches, including the first daily disposable multifocal toric contact lens and advancements in AI for surgery, as well as important clinical trial results for treatments like IMAAVY and DARZALEX. These changes reflect ongoing innovations in healthcare and medical technology.SummaryDifference100%
- Check12 days agoChange DetectedThe webpage has been updated to include new information about Johnson & Johnson's recent FDA submissions for pediatric Crohn's disease treatment and the launch of the TECNIS Odyssey IOL, which enhances vision correction options. Additionally, there are updates on investigational therapies for multiple myeloma and chronic lymphocytic leukemia, reflecting ongoing advancements in their medical offerings.SummaryDifference100%
- Check19 days agoChange DetectedThe page now highlights that TREMFYA® is the only IL-23 inhibitor proven to significantly inhibit joint structural damage in active psoriatic arthritis, and it includes new leadership information with the election of Daniel Pinto to the Board of Directors. Additionally, the ETHICON™ 4000 Stapler has been launched, showcasing advanced surgical technology.SummaryDifference100%
- Check26 days agoChange DetectedThe webpage has been updated with significant new clinical data regarding multiple myeloma treatments, including promising results for DARZALEX FASPRO® and CARVYKTI®, as well as the launch of the KINCISE™ 2 System for surgical procedures. Additionally, the page reflects a new date of June 3, 2025, indicating a focus on upcoming events and data releases.SummaryDifference100%
- Check34 days agoChange DetectedThe webpage has been updated to include new data on cancer treatments, particularly highlighting advancements in CARVYKTI® and AKEEGA® for multiple myeloma and prostate cancer, as well as the launch of SOUNDSTAR CRYSTAL™ for cardiac imaging. Additionally, the page reflects a change in the number of results from 2,134 to 2,137.SummaryDifference100%
- Check41 days agoChange DetectedThe page has been updated to include new findings from the Shockwave Medical study presented at EuroPCR 2025, highlighting the benefits of an IVL-first strategy for female patients with complex calcified lesions. Additionally, the page reflects a change in the number of results from 2,130 to 2,133.SummaryDifference100%
Stay in the know with updates to Johnson & Johnson Press Releases
Enter your email address, and we'll notify you when there's something new on the Johnson & Johnson Press Releases page.